Beta: Sign in
Shares outstandingAs of 2026-06-30 · filed common shares: 6.23M
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 10.40%
Short ratioDays to cover, as published by FINRA: 9.41
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 51.40%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 54.40%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross margin: —
Operating marginTTM to Jun 26: -2112.14%
Net margin: —
EBITDA marginTTM to Jun 26: -2083.32%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: -113.59%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: -75.57%

Growth

Revenue growth (annual YoY): -39.46%
Revenue growth (latest qtr YoY): -100.00%
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): —
EPS growth (fwd): Sign in
Net income growth (QoQ): —

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, TTM to Jun 26

-7.71

EPS (fwd)

Financial health

Cash & equivalentsas of Jun 26: $30.38M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $3.50M
Debt / equityas of Jun 26: 10.99%
Current ratioas of Jun 26: 2.19
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 2.05
Operating cash flowTTM to Jun 26: -$94.16M
Free cash flow: —
TTM revenue / diluted shareDiluted, TTM to Jun 26: 0.36

ALGS stock Statistics — Aligos Therapeutics, Inc. filings, insiders & smart money · Instaport